Regulus Therapeutics Inc.
13F holders, Q1 2025 (March 31)1holders
$1.75avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Regulus Therapeutics Inc. in their 13F filings. The largest holder was Driehaus Capital Management LLC ($1.7M).
- Company
- Regulus Therapeutics Inc.
- CUSIP
- 75915K101
- Latest filing quarter
- Q1 2025
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1.7M |
| Exits | 0 | $0 |
Ownership 1 holders
| Driehaus Capital Management LLC | 0.02% | New | 958,345 | $1.7M |
"% of holder's portfolio" is REGULUS THERAPEUTICS INC's weight in each manager's 13F, not the share of Regulus Therapeutics Inc. the manager owns.